Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisiti...
Singapore: Drug and diagnostic company Agenix announced that it was on track to submit a new drug clinical trial applic...
Nanoparticles as a drug delivery system enables unique approaches for cancer treatment. Over the last two decades, a lar...
Singapore: Prima BioMed's interim data from the CAN-003 phase II clinical trial of cancer vaccine therapy, CVac, which ...
Singapore: Starpharma reported net cash outflows from operating and investing activities for the year ending June 30, 20...
Singapore: South Australian biotechnology company, GeneWorks, developed a new DNA barcoding technology for use as a secu...
Singapore: Australia based Bionomics is recognized as the Innovative Asian Biotech of the Year at BioPharma Asia Industr...
Singapore: Regenerative medicine company Mesoblast's phase II clinical trial for lumbar spinal fusion successfully met ...
Singapore: US-based Vertex Pharmaceuticals has received Therapeutic Goods Administration (TGA) of Australia approval of ...
Singapore: A team of Australian scientists discovered new genes that show identifiable changes in the blood of people wi...
Singapore: Algae.Tec, an Australian biofuels company, has appointed Mr Colin McGregor as general manager project operati...
Singapore: Phylogica has been granted a new European patent (no. 1793841) entitled: 'Peptide inhibitors of c-Jun dimeriz...
Singapore: Irish medtech firm Mainstay Medical has started its clinical trials on Implanted Reactiv8 unit that is being ...
Singapore: International investment bank, Canaccord Genuity, expanded its Australian operations with the addition of a ...
The research and development (R&D) spend in Asia Pacific in 2011 was down by 50 percent to an average of 6.58 percen...
Singapore: The board of Genetic Technologies (GTG) has appointed Ms Alison Mew as the permanent chief executive officer...
Singapore: The Australian Institute of Health and Welfare (AIHW) has presented a report that showed that though health c...
Lack of appropriate funding for early- to mid-stage innovation companies, limited local capital, local grants for small ...
‎Singapore: Australia-based CSL Behring achieved improved pharmacokinetic results for its novel investigational re...
Singapore: Living Cell Technologies has appointed Dr Paul Tan as its chief science and medical officer. As CSMO, Dr Tan...
Singapore: Mr Jackson Huang from the Queensland Academy of Science, Mathematics and Technology, has been named Australia...
Singapore: Allied Healthcare has achieved positive results in the study of Adapt-treated tissue as a bioprosthetic subst...
Singapore: Australia based Biotron's HIV drug candidate BIT225 has demonstrated its ability to reverse HIV-induced impai...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
The medical devices industry has progressed by leaps and bounds in the recent past and this is evident from the several ...
